+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Metabolomics - Global Strategic Business Report

  • ID: 1882093
  • Report
  • Region: Global
  • 161 Pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • AB SCIEX (USA)
  • Bruker Corporation (USA)
  • Chenomx, Inc. (Canada)
  • LECO Corporation (USA)
  • Metabolon, Inc. (USA)
  • Metanomics GmbH (Germany)
  • MORE
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Metabolomics in US$ Million.

The Gobal market is analyzed by the following Applications/Technologies:
  • Bioinformatics Tools in Metabolomic Research
  • Bioanalytical Instruments & Equipment
  • Metabolomics Applications
The report profiles 29 companies including many key and niche players such as:
  • AB SCIEX
  • Agilent Technologies, Inc.
  • Biocrates Life Sciences AG
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
    Chenomx, Inc.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AB SCIEX (USA)
  • Bruker Corporation (USA)
  • Chenomx, Inc. (Canada)
  • LECO Corporation (USA)
  • Metabolon, Inc. (USA)
  • Metanomics GmbH (Germany)
  • MORE

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Metabolomics

2. INDUSTRY OVERVIEW
Metabolomics - The Current Spotlight of "Omics" Toolbox
Application Areas
Metabolomics in Cancer Detection
Growth Drivers
Market Barriers & Challenges
Metabolomics: A Regional Perspective
US and Europe Spearhead the Global Metabolomics Market
Asia-Pacific: The Fastest Growing Metabolomics Market
Biotechnology and Pharmaceutical Sectors Drive Metabolomics Research
Demand for Data Analysis Tools and Software on Rise
Bioinformatics-based Metabolomics Applications Poised to Grow
List of Select Metabolomic Analysis Software
Metabolomics in Forensics and PMI Analysis
Metabolomics Research Provides New Tools to Understand Human Health
Techniques to Examine Metabolites
Understanding Human Health and Predicting Disease Risk
Causality Assessment
NMR-based Metabolomics Screens Desirable LAB Strain with Specific Fermentation Characteristics
NMR-based Metabolomics
Metabolomics Laboratory Management Systems (LIMS): Growing in Significance
Synopsis of Select Metabolomic Databases
Some Examples of Metabolomics LIMS
Targeted Metabolomics in Newborn Screening: An Area of Success
Lack of Standardization - A Prime Concern

3. AN INSIGHT INTO METABOLOMICS APPLICATIONS
Metabolomics Gain Rapid Foothold in Drug Discovery and Toxicology Testing
Metabolomic Research - A Prospective Tool to Validate Potential Targets
Metabolite Profiling for Biomarker Discovery Gaining Prominence
Table 1: Global Biomarkers Market by Discovery Technology (2017): Percentage Share Breakdown for Bioinformatics, Imaging Technologies and Omics Technologies (includes corresponding Graph/Chart)
Oncology - A Key Focus Area for Metabolomics-Based Biomarker Discovery
Table 2: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
Table 3: New Cancer Cases in the World by Affected Site (2012) (in Thousands) (includes corresponding Graph/Chart)
Table 4: World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer-Related Deaths (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
Role of Metabolomics in Personalized Medicine
Table 5: Global Population Statistics for the 65+ Age Group (Male & Female) for Major Countries/Regions: 2015 (includes corresponding Graph/Chart)
Table 6: Global Aging Population (in Thousands) by Age Group: 2010, 2015, 2025 & 2050 (includes corresponding Graph/Chart)
Table 7: Aging (65+) Demographics as a Percentage of Total Population for Major Countries: 2010, 2015 & 2020 (includes corresponding Graph/Chart)
Table 8: Elderly Population (65+ Years) as a % of Total Population (2010, 2015 & 2025) (includes corresponding Graph/Chart)
Table 9: Global Life Expectancy at Age 60 and 80 Years: 2010-2015; 2020-2025; and 2045-2050 (includes corresponding Graph/Chart)
Table 10: Life Expectancy for Select Countries in Number of Years: 2015 (includes corresponding Graph/Chart)
Food & Nutrition Looks Up to Metabolomics
Food Safety Testing: A Statistical Snapshot
Table 11: Global Food Safety Services Market (2018): Percentage Share Breakdown of Revenue by Region (includes corresponding Graph/Chart)
Table 12: Global Food Safety Services Market (2018): Percentage Share Breakdown of Revenue by Testing Type (includes corresponding Graph/Chart)
Metabolomic Profiling in Food Safety Testing: An Opportunity to Tap
Global Food Safety Concerns: A Review
Biotechnology and Bioinformatics - The Backbone of New Testing Technologies
Plants and Agriculture: Metabolomics to Play a Vital Role
Metabolites Present in Select Agricultural Crops
Metabolomics Research on Tomato and Potato Crops
Metabolomics for Environmental Sciences
Nutrigenomics to Benefit from Metabolomics Approach

4. NOTEWORTHY TRENDS & DRIVERS
High Performance Liquid Chromatography (HPLC) Dominates the Market
Major Trends in Gas Chromatography: A Quick Review
Advances in GC Technology
Hyphenated Technologies: Order of the Day
Liquid Chromatography Gains Space in Metabolomics Analysis
MS Systems with UHPLC: A Novel Fusion
HILIC Systems Soaring in Popularity
Capillary Electrophoresis Gains Prominence

5. AN INSIGHT INTO SELECT SEPARATION AND DETECTION TECHNOLOGIES
A Primer
Separation and Detection Techniques: A Review
Separation Techniques
Gas chromatography (GC)
Capillary Electrophoresis (CE)
High Performance Liquid Chromatography (HPLC)
Ultra Performance Liquid Chromatography (UPLC)
Detection Techniques
Mass Spectrometry (MS)
Nuclear Magnetic Resonance (NMR) Spectroscopy (NMR)
Surface-based Mass Analysis
Common and Prospective Technologies in Metabolite Profiling

6. METABOLOMICS - AN OVERVIEW
Introduction
Systems Biology Framework
Metabolome
Metabolites
Evolution of Metabolomics over the Years
Metabolomics Vs. Metabonomics
Analytical Methods
Key Application Areas
Toxicity Assessment/Toxicology
Functional Genomics
Nutrigenomics
Conceptual Approaches in Metabolomics
Target Analysis
Metabolite Profiling
Metabolomics
Metabolic Fingerprinting
Technological Advancements in Metabolomics
Metabolomics as Systems Biology Tool
Metabolomics: A Link between Genetics and Ecology
Limitations
An Overview of Metabolomics Research
Adoption of Metabolomics Research by Type of Entity
Implementation of Metabolomics Research by Nature of Study
Implementation of Metabolomics Research by Type of Laboratory
Key Issues Associated with Metabolomics Study

7. COMPETITIVE LANDSCAPE
A Highly Consolidated Market

7.1 Focus on Select Players
AB SCIEX (USA)
Agilent Technologies, Inc. (USA)
Biocrates Life Sciences AG (Austria)
Metanomics GmbH (Germany)
Bio-Rad Laboratories, Inc. (USA)
Bruker Corporation (USA)
Chenomx, Inc. (Canada)
Human Metabolome Technologies, Inc. (Japan)
LECO Corporation (USA)
Metabolon, Inc. (USA)
Shimadzu Corporation (Japan)
SiDMAP, LLC (USA)
Thermo Fisher Scientific, Inc. (USA)
Waters Corporation (USA)

7.2 Product Introductions/Innovations
Bruker Unveils B.I.QUANT-PS™
Thermo Scientific Introduces Thermo Scientific Compound Discoverer 3.0
Metabolon Introduces Meta UDx™ Test
HMT Publishes Diagnostic Plasma Metabolite Biomarker for MDD
Bruker Launches New Mass Spectrometry Solutions
Thermo Scientific Unveils Thermo Scientific Orbitrap Fusion Lumos Tribrid Mass Spectrometer
Thermo Fisher and BIOCRATES Introduce Metabolome Analysis Kit
SCIEX Unveils Biotransform Solution

7.3 Recent Industry Activity
Thermo Fisher Opens U.S. Precision Medicine Science Center
Metabolon Bags Contract for Metabolomic Profiling from US Veterans Administration
Metabolon and Dian Diagnostics Achieve Validation for Metabolon's Proprietary Metabolomics Platform
SCIEX and IROA Sign Co-Marketing Agreement
BIOCRATES Takes Over Metanomics Health
Agilent Acquires Luxcel Biosciences
Metabolon Takes Over Metabolomic Discoveries
Metabolon and ADLQ to Establish Metabolomics Lab in Qatar
Metabolon Enters into Joint Laboratory Licensing Agreement with Dian
Metabolon and InnVentis Enter into Agreement for Chronic Inflammatory Diseases

8. GLOBAL MARKET PERSPECTIVE
Table 13: World Recent Past, Current & Future Analysis for Metabolomics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 14: World Historic Review for Metabolomics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 15: World 14-Year Perspective for Metabolomics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
By Application/Technology
Table 16: World Recent Past, Current & Future Analysis for Metabolomics by Application/Technology - Bioinformatics Tools in Metabolomic Research, Bioanalytical Instruments and Equipment, and Metabolomics Applications Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 17: World Historic Review for Metabolomics by Application/Technology - Bioinformatics Tools in Metabolomic Research, Bioanalytical Instruments and Equipment, and Metabolomics Applications Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 18: World 14-Year Perspective for Metabolomics by Application/Technology - Percentage Breakdown of Revenues for Bioinformatics Tools in Metabolomic Research, Bioanalytical Instruments and Equipment, and Metabolomics Applications Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

9. REGIONAL MARKET PERSPECTIVE

9.1 The United States
A. Market Analysis
Current and Future Analysis
Strong Emphasis on Metabolomics Research
Personalized Medicine - An Opportunity for Metabolomics Technology
B. Market Analytics
Table 19: US Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 20: US Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

9.2 Canada
A. Market Analysis
Current and Future Analysis
Strong R&D Base Bodes Well for the Market
B. Market Analytics
Table 21: Canadian Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 22: Canadian Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

9.3 Japan
Market Analysis
Table 23: Japanese Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 24: Japanese Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

9.4 Europe
A. Market Analysis
Current and Future Analysis
Personalized Medicine: Opportunities for Growth
Table 25: Population Breakup by Age Group for Select European Countries: 2016 (As a % of Total Population) (includes corresponding Graph/Chart)
B. Market Analytics
Table 26: European Recent Past, Current & Future Analysis for Metabolomics by Geographic Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 27: European Historic Review for Metabolomics by Geographic Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 28: European 14-Year Perspective for Metabolomics by Geographic Region - Percentage Breakdown of Dollar Revenues for France, Germany, Italy, UK, and Rest of Europe Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

9.4.1 France
A. Market Analysis
Current and Future Analysis
Government Support Aids Development
B. Market Analytics
Table 29: French Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 30: French Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

9.4.2 Germany
A. Market Analysis
Current and Future Analysis
A Major European Market
B. Market Analytics
Table 31: German Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 32: German Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

9.4.3 Italy
Market Analysis
Table 33: Italian Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 34: Italian Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

9.4.4 The United Kingdom
A. Market Analysis
Current and Future Analysis
Focus on Personalized Medicine to Drive the Market
B. Market Analytics
Table 35: UK Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 36: UK Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

9.4.5 Rest of Europe
A. Market Analysis
Current and Future Analysis
Overview of Select Regional Markets
Austria
Finland
B. Market Analytics
Table 37: Rest of Europe Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 38: Rest of Europe Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

9.5 Asia-Pacific
A. Market Analysis
Current and Future Analysis
Australia - An Overview
University of Melbourne at the Forefront of Metabolomics Research
B. Market Analytics
Table 39: Asia-Pacific Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 40: Asia-Pacific Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

9.6 Latin America
Market Analysis
Table 41: Latin American Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 42: Latin American Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

9.7 Rest of World
Market Analysis
Table 43: Rest of World Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 44: Rest of World Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

10. COMPANY PROFILES
Total Companies Profiled: 29 (including Divisions/Subsidiaries - 30)
The United States (20)
Canada (2)
Japan (3)
Europe (5)
Germany (1)
Spain (1)
Rest of Europe (3)

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • AB SCIEX (USA)
  • Agilent Technologies, Inc. (USA)
  • Biocrates Life Sciences AG (Austria)
  • Metanomics GmbH (Germany)
  • Bio-Rad Laboratories, Inc. (USA)
  • Bruker Corporation (USA)
  • Chenomx, Inc. (Canada)
  • Human Metabolome Technologies, Inc. (Japan)
  • LECO Corporation (USA)
  • Metabolon, Inc. (USA)
  • Shimadzu Corporation (Japan)
  • SiDMAP, LLC (USA)
  • Thermo Fisher Scientific, Inc. (USA)
  • Waters Corporation (USA)
Note: Product cover images may vary from those shown
Adroll
adroll